JMP Securities Keeps Their Buy Rating on Kaltura (KLTR)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Kaltura (KLTR – Research Report) today and set a price target of $4.00. The ...
JMP Securities Keeps Their Buy Rating on Sprinklr (CXM)
In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Sprinklr (CXM – Research Report), with a price ...
TipRanks on MSN12h
Enova International management to meet virtually with Citizens JMP
Virtual Meeting to be held on March 14 hosted by Citizens JMP. Published first on TheFly – the ultimate source for real-time, market-moving ...
JMP Securities Reaffirms Buy on MongoDB, Inc. (MDB) Despite Mixed Guidance
We recently compiled a list of the 10 Hot AI News Updates Analysts are Monitoring. In this article, we are going to take a ...
Investing Snacks6d
Stryker Downgraded to Hold Amid Mixed Analyst Ratings
StockNews.com downgraded Stryker from a "buy" to a "hold," adding to mixed analyst ratings. While some firms like Needham and ...
Investing21d
Solid Biosciences shares gain on JMP Market Outperform rating
On Wednesday, JMP Securities reaffirmed their optimistic stance on Solid Biosciences (NASDAQ:SLDB), maintaining a Market Outperform rating with a steady price target of $15.00. The stock, currently ...
Investing22d
Solid Biosciences shares gain on JMP Market Outperform rating
On Wednesday, JMP Securities reaffirmed their optimistic stance on Solid Biosciences (NASDAQ:SLDB), maintaining a Market Outperform rating with a steady price target of $15.00. The stock ...
Investing22d
JMP SECURITIES REITERATES ASTRIA THERAPEUTICS OUTPERFORM RATING
On Tuesday, JMP Securities maintained its Market Outperform rating for Astria Therapeutics (NASDAQ:ATXS) with a steady price target of $26.00, representing significant upside potential from the ...